Hypothalamic-pituitary-adrenal axis and bipolar disorder.

[1]  A. Young,et al.  Improvements in Neurocognitive Function and Mood Following Adjunctive Treatment with Mifepristone (RU-486) in Bipolar Disorder , 2004, Neuropsychopharmacology.

[2]  E. Vieta,et al.  Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. , 2004, Bipolar disorders.

[3]  A. Young,et al.  Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder , 2004, British Journal of Psychiatry.

[4]  S. Hodgins,et al.  High levels of cortisol among adolescent offspring of parents with bipolar disorder: a pilot study , 2004, Psychoneuroendocrinology.

[5]  H. Grunze,et al.  Pharmacological treatment of acute mania in Europe: EMBLEM baseline findings , 2004 .

[6]  F. Holsboer,et al.  Pharmacological and Nonpharmacological Factors Influencing Hypothalamic–Pituitary–Adrenocortical Axis Reactivity in Acutely Depressed Psychiatric In-patients, Measured by the Dex-CRH Test , 2003, Neuropsychopharmacology.

[7]  M. Alda,et al.  The Cortisol Awakening Response in Bipolar Illness: A Pilot Study , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[8]  F. Holsboer,et al.  Effect of Chronic Administration of Selective Glucocorticoid Receptor Antagonists on the Rat Hypothalamic–Pituitary–Adrenocortical Axis , 2003, Neuropsychopharmacology.

[9]  K. J. Parker,et al.  Neuroendocrine aspects of hypercortisolism in major depression , 2003, Hormones and Behavior.

[10]  E. Pascual.  Novedades en el tratamiento del trastorno bipolar , 2003 .

[11]  A. Schatzberg,et al.  An open label trial of C-1073 (mifepristone) for psychotic major depression* , 2002, Biological Psychiatry.

[12]  M. Bauer,et al.  Lithium Augmentation Increases the ACTH and Cortisol Response in the Combined DEX/CRH Test in Unipolar Major Depression , 2002, Neuropsychopharmacology.

[13]  P. Cervantes,et al.  Circadian secretion of cortisol in bipolar disorder. , 2001, Journal of psychiatry & neuroscience : JPN.

[14]  Alan F. Schatzberg,et al.  Rapid Reversal of Psychotic Depression Using Mifepristone , 2001, Journal of clinical psychopharmacology.

[15]  O. Wolkowitz,et al.  Antiglucocorticoid drugs in the treatment of depression , 2001, Expert opinion on investigational drugs.

[16]  D. Kupfer,et al.  Decreased pituitary volume in patients with bipolar disorder , 2001, Biological Psychiatry.

[17]  Nichole E Carlson,et al.  Twenty-Four-Hour ACTH and Cortisol Pulsatility in Depressed Women , 2001, Neuropsychopharmacology.

[18]  F. Holsboer,et al.  Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. , 2001, Journal of psychiatric research.

[19]  A. Schatzberg,et al.  24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. , 2000, Archives of general psychiatry.

[20]  Decreased glucocorticoid receptor mRNA levels in individuals with depression, bipolar disorder and schizophrenia , 2000, Schizophrenia Research.

[21]  A. Rush,et al.  Hippocampal Remodeling and Damage by Corticosteroids: Implications for Mood Disorders , 1999, Neuropsychopharmacology.

[22]  J. Rybakowski,et al.  The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. , 1999, Journal of psychiatric research.

[23]  B. Stanton,et al.  Neuropsychological function in euthymic patients with bipolar disorder , 1999, British Journal of Psychiatry.

[24]  T. Robbins,et al.  The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers , 1999, Psychopharmacology.

[25]  E. Vieta,et al.  Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients , 1999, Psychological Medicine.

[26]  F. Holsboer,et al.  The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. , 1999, Journal of psychiatric research.

[27]  L. Altshuler,et al.  Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. , 1998, Archives of general psychiatry.

[28]  Bruce S. McEwen,et al.  The acute effects of corticosteroids on cognition: integration of animal and human model studies , 1997, Brain Research Reviews.

[29]  A. Rush,et al.  Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression , 1997, Biological Psychiatry.

[30]  J. Vallejo,et al.  Prediction of depressive relapse in remitted bipolar patients using corticotrophin‐releasing hormone challenge test , 1997, Acta psychiatrica Scandinavica.

[31]  I. Heuser,et al.  Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. , 1996, The American journal of psychiatry.

[32]  I. Heuser,et al.  Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I , 1995, Biological Psychiatry.

[33]  C. Perrin,et al.  Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant , 1995, Brain Research.

[34]  F. Holsboer,et al.  Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. , 1995, Neuroendocrinology.

[35]  M. Laraia,et al.  Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial. , 1995, The American journal of psychiatry.

[36]  I. Heuser,et al.  The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. , 1994, Journal of psychiatric research.

[37]  B. Budziszewska,et al.  The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats , 1993, Neuropharmacology.

[38]  D. Filipini,et al.  Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486. , 1993, Journal of psychiatry & neuroscience : JPN.

[39]  L. Altshuler.  Bipolar disorder: Are repeated episodes associated with neuroanatomic and cognitive changes? , 1993, Biological Psychiatry.

[40]  C. Nemeroff,et al.  The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. , 1993, Ciba Foundation symposium.

[41]  G. Fink,et al.  Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. , 1992, Neuroendocrinology.

[42]  E. Robins,et al.  Hypothalamic‐pituitary‐adrenocortical function in mixed and pure mania , 1992, Acta psychiatrica Scandinavica.

[43]  N. Barden,et al.  Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain , 1991, Psychoneuroendocrinology.

[44]  F. Goodwin.  Manic-Depressive Illness , 1990 .

[45]  N. Barden,et al.  Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures. , 1989, Brain research. Molecular brain research.

[46]  S. Yucun,et al.  Dexamethasone suppression test and urinary MHPG · SO4 determination in depressive disorders , 1987, Biological Psychiatry.

[47]  J. Nurnberger,et al.  CSF Neuropeptides in Euthymic Bipolar Patients and Controls , 1987, British Journal of Psychiatry.

[48]  B. McEwen,et al.  The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. , 1986, Endocrine reviews.

[49]  C. Kilts,et al.  Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. , 1984, Science.

[50]  S. Shukla,et al.  Consistent dexamethasone suppression test results with mania and depression in bipolar illness. , 1984, The American journal of psychiatry.

[51]  R. Post,et al.  Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. , 1984, The American journal of psychiatry.

[52]  R. Krishnan,et al.  Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms. , 1983, The American journal of psychiatry.

[53]  C. Nemeroff,et al.  The dexamethasone suppression test in mixed bipolar disorder. , 1983, The American journal of psychiatry.

[54]  V. Reus,et al.  ACTH levels after the dexamethasone suppression test in depression. , 1982, The New England journal of medicine.

[55]  W. Mandel,et al.  Calcium for myocardial depression from verapamil. , 1982, The New England journal of medicine.

[56]  B. Carroll,et al.  A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. , 1981, Archives of general psychiatry.

[57]  G. Winokur,et al.  Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification. , 1980, Archives of general psychiatry.

[58]  W. D. Nunn,et al.  Pituitary-adrenal function in depressed patients: Resistance to dexamethasone suppression☆ , 1975 .

[59]  R. Michael,et al.  INTERRELATIONSHIPS BETWEEN THE ENDOCRINE SYSTEM NEUROPSYCHIATRY. , 1963, International review of neurobiology.